STEMPOINT CAPITAL LP
Adviser information for STEMPOINT CAPITAL LP last updated from Form ADV on March 22nd, 2024. Select data displayed; additional Form ADV, Form D, Form 13F and other data is available from the Fincoded API.
Advisory Business
Type of Organization | Limited Partnership |
---|---|
Fiscal Year End | DECEMBER |
Legal Location | Delaware, United States |
Employees
Total Number of Employees | 5 |
---|---|
Investment Advisory/Research | 3 |
Registered Broker-Dealer Representatives | 0 |
Registered State Investment Advisers | 0 |
Licensed Agents of an Insurance Company | 0 |
No. of Firms/People that Solicit Clients | 1 |
RAUM
Provides Management of Securities Portfolios | Yes |
---|
Type | Accounts | RAUM |
---|---|---|
Discretionary | 4 | $440.9M |
Non-Discretionary | 0 | $0 |
Total | 4 | $440.9M |
Clients
Type | Number | RAUM |
---|---|---|
Individuals | 0 | $0 |
HNW Individuals | 0 | $0 |
Banking or thrift institutions | 0 | $0 |
Investment companies | 0 | $0 |
Business development companies | 0 | $0 |
Pooled investment vehicles | 3 | $166.6M |
Pension and profit sharing plans | 0 | $0 |
Charitable organizations | 0 | $0 |
State or municipal gov entities | 0 | $0 |
Other investment advisers | 0 | $0 |
Insurance companies | 0 | $0 |
Sovereign wealth funds and foreign official institutions | 0 | $0 |
Corporations or other businesses | <5 | $274.3M |
Other | 0 | $0 |
Type | Number |
---|---|
No. of Non-RAUM Clients | 0 |
No. of Non-U.S. Clients | 0 |
Services
Advisory Services | Portfolio management for pooled investment vehicles |
---|---|
Compensation | % of AUMPerformance-based fees |
Other Business Activities | Commodity pool operator or commodity trading advisor |
Principal Office
520 MADISON AVE19TH FLOOR
NEW YORK
NY
United States
Monday - Friday, 7:00 AM - 5:00 PM EST
Tel: 212-540-4099, Fax: None
Chief Compliance Officer
SEAN CHUA TAN
CHIEF OPERATING OFFICER
520 MADISON AVE
19TH FLOOR
NEW YORK
NY
United States
Tel:
212-540-4099
S***@*******************M
(Full email address available in API data)
Regulatory Contact
MICHELLE ROSS
CHIEF INVESTMENT OFFICER
520 MADISON AVE
19TH FLOOR
NEW YORK
NY
United States
Tel:
212-540-4098
M*******@*******************M
(Full email address available in API data)
Industry Affiliates
STEMPOINT CAPITAL MANAGEMENT GP LLC | Sponsor, GP, manager of pooled investment vehicles |
Private Funds
Name | Type | Assets $USD | Min Investment $USD | No. Owners |
---|---|---|---|---|
STEMPOINT CAPITAL MASTER FUND LP | Hedge Fund | $64.8M | $1.0M | 22 |
Control Persons
Name | Type | Entity | Title | Since | Ownership |
---|---|---|---|---|---|
STEMPOINT CAPITAL MANAGEMENT GP LLC | Domestic Entity | – | GP OF THE IM | 09/2022 | < 5% |
TAN, SEAN, CHUA | Individual | – | CCO, COO AND MANAGING PARTNER | 09/2022 | 25-50% |
ROSS, MICHELLE | Individual | – | CIO & MANAGING PARTNER | 09/2022 | > 75% |
ROSS, MICHELLE | Individual | STEMPOINT CAPITAL MANAGEMENT GP LLC | CIO & MANAGING PARTNER | 09/2022 | > 75% |
Gorynski, Robert | Individual | – | CFO | 08/2023 | < 5% |
No. Employees, Historic
RAUM, Historic
No. Clients, Historic
Holdings
From latest 13F, filed August 13th, 2024 for period ending June 30th, 2024
Name | Class | Value $USD | # Shares | Private Fund |
---|---|---|---|---|
AMICUS THERAPEUTICS INC | COM | 15M | 1M | – |
APPLIED THERAPEUTICS INC | COM | 10M | 2M | – |
ARCELLX INC | COMMON STOCK | 15M | 281K | – |
ARCUTIS BIOTHERAPEUTICS INC | COM | 350K | 500K | – |
ARCUTIS BIOTHERAPEUTICS INC | COM | 9M | 965K | – |
AUTOLUS THERAPEUTICS PLC | SPON ADS | 9M | 3M | – |
BIOHAVEN LTD | COM | 8M | 233K | – |
BLACK DIAMOND THERAPEUTICS I | COM | 3M | 674K | – |
CABALETTA BIO INC | COM | 9M | 1M | – |
CELLDEX THERAPEUTICS INC NEW | COM NEW | 5M | 144K | – |
CORBUS PHARMACEUTICALS HLDGS | COM NEW | 5M | 101K | – |
CRINETICS PHARMACEUTICALS IN | COM | 25M | 551K | – |
DENALI THERAPEUTICS INC | COM | 6M | 251K | – |
EDGEWISE THERAPEUTICS INC | COM | 5M | 271K | – |
FULCRUM THERAPEUTICS INC | COM | 4M | 696K | – |
GSK PLC | SPONSORED ADR | 9M | 246K | – |
HELIX ACQUISITION CORP II | CL A ORD SHS | 2M | 200K | – |
IDEAYA BIOSCIENCES INC | COM | 4M | 102K | – |
IMMATICS N.V | SHS | 6M | 502K | – |
IMMUNOCORE HLDGS PLC | ADS | 12M | 339K | – |
IMMUNOVANT INC | COM | 27M | 1M | – |
INSMED INC | COM PAR $.01 | 6M | 87K | – |
JANUX THERAPEUTICS INC | COM | 4M | 93K | – |
JASPER THERAPEUTICS INC | COM NEW | 3M | 144K | – |
KALVISTA PHARMACEUTICALS INC | COM | 9M | 737K | – |
LARIMAR THERAPEUTICS INC | COM | 5M | 704K | – |
MERCK & CO INC | COM | 10M | 82K | – |
MERUS N V | COM | 17M | 289K | – |
NEUROGENE INC | COM | 3M | 79K | – |
NURIX THERAPEUTICS INC | COM | 4M | 203K | – |
PERCEPTIVE CAP SOLUTIONS COR | CL A ORD SHS | 2M | 150K | – |
PERSPECTIVE THERAPEUTICS INC | COM NEW | 3M | 344K | – |
PRAXIS PRECISION MEDICINES I | COM NEW | 1M | 29K | – |
PROTARA THERAPEUTICS INC | COM STK | 2M | 984K | – |
PYXIS ONCOLOGY INC | COMMON STOCK | 4M | 1M | – |
ROIVANT SCIENCES LTD | SHS | 29M | 3M | – |
SILENCE THERAPEUTICS PLC | ADS | 2M | 125K | – |
SPYRE THERAPEUTICS INC | COM NEW | 4M | 150K | – |
SURROZEN INC | COM NEW | 2M | 144K | – |
SYNDAX PHARMACEUTICALS INC | COM | 29M | 1M | – |
TSCAN THERAPEUTICS INC | COM | 5M | 845K | – |
VIGIL NEUROSCIENCE INC | COM | 3M | 744K | – |
VISTAGEN THERAPEUTICS INC | COM | 2M | 617K | – |
VISTAGEN THERAPEUTICS INC | COM | 4M | 1M | – |